BLOG

Developing next-generation CAR T cell therapies to bridge the gap in personalised medicine

Filippo Petti, Chief Executive Officer at Celyad, delves into the disruptive potential of CAR T therapies in treating cancer, and explores the challenges that have held the technology back thus far.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}